Cough & Lung Sound Measures for Clinical Trials
RESP® Platform Overview
The RESP® Platform offers clinical trial teams a new approach to understanding treatment response by capturing respiratory symptoms in daily life, enabling more robust evidence generation and clearer differentiation of clinical programs.
- Patient-Friendly: Wireless, discreet form factor and privacy-preserving
- Multi-Parameter: Comprehensive respiratory and physiological measures
- Validated Reporting: Automated or manual (human) overread to meet endpoint requirements
Measures
A robust combination of multi-modal data alongside patient reported outcomes (PROs)
-
-
-
-
- Cough Frequency (24-hour)
- Cough Bouts
- Cough Sound Intensity
- Wheeze, Rhonchi, Crackles
- Breathing Patterns*
- Respiratory Rate*
- Heart Rate & Heart Rate Variability*
- Orientation (e.g. Supine or Upright)*
- Sleep/Wake*
- Activity Levels*
-
-
-
*Measurement not FDA cleared but may be collected in clinical trials
Metrics-at-a-Glance
1.5M
Lung Sounds Captured
50M
Breaths Captured
5
Continents
34
Countries
36
Languages
245
Sites
Device Selection for Varying Applications
Digital Measures for Multiple Indications
| Cough | Wheeze | Crackles | Rhonchi | Respiratory Rate* | Heart Rate* | Activity* | |
| Chronic Cough | |||||||
| Pulmonary Fibrosis | |||||||
| Bronchiectasis | |||||||
| COPD | |||||||
| Asthma | |||||||
| Infectious Diseases | |||||||
| Lung Cancer | |||||||
| Congestive Heart Failure |
- Chronic Cough
- IPF
- Bronchitis
- COPD
- Asthma
- RSV
- Covid-19
- Heart Failure
*Measurement not FDA cleared but may be collected in clinical trials
Why Include Cough & Lung Sounds as Endpoints?
- Strengthen evidence into how patients feel and function
- Reduce reliance on PROs to demonstrate treatment efficacy
- Differentiate your program to patients and regulators
- Uncover signals that may point to new or expanded indications
- Identify new pharmacologic insights into your treatment
Features & Specifications
-
- Wireless and discreet
- Passive and continuous
- Data transfer to cloud
- 24+ hour battery life
- Water resistant
- Patient-privacy preserving (HIPAA compliant)
- Flexible reporting including automated or human analysis of cough and lung sounds
- Verifications: FDA 510(k) Class II and CE Mark (RESP Biosensor only)
Publications
Cough Detection Performance of the CoughCheck Algorithm in Subjects with Subacute Cough
Poster Presentation, American Thoracic Society, 2025
Poster Presentation, American Cough Conference, 2023
Talk to our Team
Explore using the RESP® Biosensor in your next study





